Evidence map›Paper›PMID 29218308›Full record

ReviewFrontiers in cell and developmental biology2017

Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research.

Leah J Campbell, David R Hyde

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. The regeneration-responsive elementFrontiers in molecular neuroscience · 2023
    Article
  3. Article
  4. Noninvasive Imaging of Cone Ablation and Regeneration in Zebrafish.Translational vision science & technology · 2020
    Article
  5. Review
  6. Article
  7. Review
  8. Frontiers in cell and developmental biology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Leah J CampbellDepartment of Biological Sciences, Center for Zebrafish Research and Center for Stem Cells and Regenerative Medicine, University of Notre Dame, Notre Dame, IN, United States.
David R HydeDepartment of Biological Sciences, Center for Zebrafish Research and Center for Stem Cells and Regenerative Medicine, University of Notre Dame, Notre Dame, IN, United States.

Funding

Genetic Hierarchy Underlying Photoreceptor RegenerationR01EY018417 · NEI · UNIVERSITY OF NOTRE DAME · PI HYDE, DAVID R, THUMMEL, RYAN · 2009 to 2012
$1.3M
Roles of TNFa and Notch to Initiate Retinal Regeneration from Muller gliaR01EY024519 · NEI · UNIVERSITY OF NOTRE DAME · PI HYDE, DAVID R · 2015 to 2017
$1.1M
NEI NIH HHS R01 EY018417NEI NIH HHS R01 EY024519
6 · The paper itself

Abstract

While retinal degeneration and disease results in permanent damage and vision loss in humans, the severely damaged zebrafish retina has a high capacity to regenerate lost neurons and restore visual behaviors. Advancements in understanding the molecular and cellular basis of this regeneration response give hope that strategies and therapeutics may be developed to restore sight to blind and visually-impaired individuals. Our current understanding has been facilitated by the amenability of zebrafish to molecular tools, imaging techniques, and forward and reverse genetic approaches. Accordingly, the zebrafish research community has developed a diverse array of research tools for use in developing and adult animals, including toolkits for facilitating the generation of transgenic animals, systems for inducible, cell-specific transgene expression, and the creation of knockout alleles for nearly every protein coding gene. As CRISPR/Cas9 genome editing has begun to revolutionize molecular biology research, the zebrafish community has responded in stride by developing CRISPR/Cas9 techniques for the zebrafish as well as incorporating CRISPR/Cas9 into available toolsets. The application of CRISPR/Cas9 to retinal regeneration research will undoubtedly bring us closer to understanding the mechanisms underlying retinal repair and vision restoration in the zebrafish, as well as developing therapeutic approaches that will restore vision to blind and visually-impaired individuals. This review focuses on how CRISPR/Cas9 has been integrated into zebrafish research toolsets and how this new tool will revolutionize the field of retinal regeneration research.

Indexed as

CRISPR/Cas9Müller glianeuronal progenitor cellregenerationretinazebrafish

Identifiers

PMID29218308
PMCPMC5703712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.